With the advancement of functional nanomaterials and aptamer selection technologies,
aptamer functionalized nanomaterials (AFMs) open various methods to design new sensing …

Abstract Development of drug‐delivery systems that selectively target neoplastic cells has
been a major goal of nanomedicine. One major strategy for achieving this milestone is to …

Nanomedicines (NMs) offer new solutions for cancer diagnosis and therapy. However,
extension of progression-free interval and overall survival time achieved by Food and Drug …

Despite numerous advances in the use of DNA as building blocks to assemble complex
structures, the dearth of strategies that allow for protease-controlled in situ DNA assembly in …

Distinguishing cancer cells from normal cells through surface receptors is vital for cancer
diagnosis and targeted therapy. Metabolic glycoengineering of unnatural sugars provides a …

Nanomedicine, the use of nanotechnology for biomedical applications, has potential to
change the landscape of the diagnosis and therapy of many diseases. In the past several …

Background AS1411 is a 26-mer G-rich DNA oligonucleotide that forms a variety of G-
quadruplex structures. It was identified based on its cancer-selective antiproliferative activity …

Ultrasmall nanoparticulate materials with core sizes in the 1-3 nm range bridge the gap
between single molecules and classical, larger-sized nanomaterials, not only in terms of …

Nuclear medicine imaging has been developed as a powerful diagnostic approach for
cancers by detecting gamma rays directly or indirectly from radionuclides to construct …

Aptamers, including DNA, RNA and peptide aptamers, are a group of promising recognition
units that can specifically bind to target molecules and cells. Due to their excellent specificity …